NASDAQ:TNDM - Tandem Diabetes Care Stock Price, Price Target & More

$7.37 -0.07 (-0.94 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$7.37
Today's Range$7.23 - $7.53
52-Week Range$2.14 - $12.20
Volume821,201 shs
Average Volume1.57 million shs
Market Capitalization$332.56 million
P/E Ratio-0.57
Dividend YieldN/A
Beta-0.35

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; t:slim X2 with G5 integration; and Tandem Device Updater, a PC and Mac-compatible tool that allows users to update their pump's software. In addition, the company offers t:connect diabetes management application, a cloud-based data management application, which provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers; t:lock cartridge and infusion set products; and various pump accessories. Its products in development include automated insulin delivery systems; t:slim X2 with Basal IQ; t:slim X2 with control IQ; t:sport insulin delivery system; and connected (mobile) health mobile application. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.

Receive TNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TNDM
CUSIPN/A
Phone858-366-6900

Debt

Debt-to-Equity Ratio-2.63%
Current Ratio1.78%
Quick Ratio1.03%

Price-To-Earnings

Trailing P/E Ratio-0.57
Forward P/E Ratio-5.19
P/E GrowthN/A

Sales & Book Value

Annual Sales$107.60 million
Price / Sales3.06
Cash FlowN/A
Price / CashN/A
Book Value($2.88) per share
Price / Book-2.56

Profitability

EPS (Most Recent Fiscal Year)($12.87)
Net Income$-73,030,000.00
Net Margins-67.87%
Return on EquityN/A
Return on Assets-74.04%

Miscellaneous

Employees574
Outstanding Shares44,700,000

How to Become a New Pot Stock Millionaire

Tandem Diabetes Care (NASDAQ:TNDM) Frequently Asked Questions

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

When did Tandem Diabetes Care's stock split? How did Tandem Diabetes Care's stock split work?

Tandem Diabetes Care's stock reverse split before market open on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care (NASDAQ:TNDM) issued its quarterly earnings data on Thursday, March, 1st. The medical device company reported ($1.23) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.11) by $0.13. The medical device company earned $40 million during the quarter, compared to analyst estimates of $38.41 million. The business's revenue for the quarter was up 61.3% on a year-over-year basis. During the same period last year, the company earned ($0.48) earnings per share. View Tandem Diabetes Care's Earnings History.

When is Tandem Diabetes Care's next earnings date?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Tandem Diabetes Care.

What price target have analysts set for TNDM?

8 analysts have issued 1-year price targets for Tandem Diabetes Care's stock. Their predictions range from $3.00 to $17.00. On average, they expect Tandem Diabetes Care's stock price to reach $9.6429 in the next twelve months. View Analyst Ratings for Tandem Diabetes Care.

Are investors shorting Tandem Diabetes Care?

Tandem Diabetes Care saw a increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,632,952 shares, an increase of 138.5% from the February 28th total of 1,103,935 shares. Based on an average trading volume of 1,667,602 shares, the short-interest ratio is currently 1.6 days. Approximately 8.3% of the shares of the company are sold short.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:
  • Mr. Kim D. Blickenstaff, Pres, CEO & Director (Age 66)
  • Ms. Leigh A. Vosseller, Sr. VP, CFO, Treasurer & Principal Accounting Officer (Age 45)
  • Mr. John F. Sheridan, Exec. VP & COO (Age 63)
  • Ms. Susan M. Morrison, Exec. VP & Chief Admin. Officer (Age 39)
  • Mr. David B. Berger, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48)

Has Tandem Diabetes Care been receiving favorable news coverage?

News articles about TNDM stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Tandem Diabetes Care earned a coverage optimism score of 0.16 on Accern's scale. They also gave news stories about the medical device company an impact score of 45.96 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Tandem Diabetes Care?

Shares of TNDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of TNDM stock can currently be purchased for approximately $7.37.

How big of a company is Tandem Diabetes Care?

Tandem Diabetes Care has a market capitalization of $332.56 million and generates $107.60 million in revenue each year. The medical device company earns $-73,030,000.00 in net income (profit) each year or ($12.87) on an earnings per share basis. Tandem Diabetes Care employs 574 workers across the globe.

How can I contact Tandem Diabetes Care?

Tandem Diabetes Care's mailing address is 11075 ROSELLE STREET, San Diego CA, 92121. The medical device company can be reached via phone at 858-366-6900 or via email at [email protected]


MarketBeat Community Rating for Tandem Diabetes Care (TNDM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  220 (Vote Outperform)
Underperform Votes:  245 (Vote Underperform)
Total Votes:  465
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe TNDM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TNDM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tandem Diabetes Care (NASDAQ:TNDM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Tandem Diabetes Care in the last 12 months. Their average twelve-month price target is $9.6429, suggesting that the stock has a possible upside of 30.84%. The high price target for TNDM is $17.00 and the low price target for TNDM is $3.00. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.632.502.332.44
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.6429$10.0625$13.00$32.4286
Price Target Upside: 30.84% upside165.50% upside343.69% upside5,480.55% upside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/6/2018OppenheimerSet Price TargetBuy$8.00HighView Rating Details
3/28/2018CowenUpgradeMarket Perform -> OutperformMediumView Rating Details
3/23/2018Robert W. BairdUpgradeNeutral -> OutperformHighView Rating Details
3/2/2018Stifel NicolausReiterated RatingHold$4.00HighView Rating Details
2/27/2018CitigroupInitiated CoverageOutperform$5.50LowView Rating Details
10/10/2017WedbushReiterated RatingOutperform$50.00 -> $17.00N/AView Rating Details
10/6/2017Piper JaffrayReiterated RatingHold$15.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche BankLower Price TargetBuy$140.00 -> $90.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Tandem Diabetes Care (NASDAQ:TNDM) Earnings History and Estimates Chart

Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Earnings Estimates

2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)

Tandem Diabetes Care (NASDAQ TNDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018N/AView Earnings Details
3/1/2018Q4 2017($1.1050)($1.2310)$38.41 million$40.00 millionViewListenView Earnings Details
10/26/2017Q3 2017($3.74)($3.09)$25.92 million$27.00 millionViewN/AView Earnings Details
7/27/2017Q2 2017($4.80)($4.40)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($6.60)($7.50)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($6.50)($4.80)$22.75 million$24.80 millionViewListenView Earnings Details
11/1/2016Q3 2016($5.90)($9.70)$23.42 million$12.29 millionViewN/AView Earnings Details
7/28/2016Q216($6.50)($6.00)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($6.90)($6.80)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($5.10)($4.00)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($8.00)($6.50)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($7.10)($6.50)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($7.90)($8.30)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($8.10)($7.80)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($8.20)($8.50)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($9.10)($8.30)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($6.90)($9.60)$8.24 million$8.10 millionViewN/AView Earnings Details
3/6/2014Q4 2013($13.10)($16.00)$8.64 million$10.25 millionViewN/AView Earnings Details
11/8/2011$2.50$1.80ViewN/AView Earnings Details
8/9/2011$2.60$2.00ViewN/AView Earnings Details
5/10/2011$2.40$2.40ViewN/AView Earnings Details
3/14/2011$2.90$1.80ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Tandem Diabetes Care (NASDAQ:TNDM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 20.90%
Institutional Ownership Percentage: 8.77%
Insider Trading History for Tandem Diabetes Care (NASDAQ:TNDM)
Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2018Dick AllenDirectorBuy25,539$3.88$99,091.32View SEC Filing  
2/9/2018Christopher J TwomeyDirectorBuy75,000$2.00$150,000.00View SEC Filing  
2/9/2018Kim D BlickenstaffCEOBuy750,000$2.00$1,500,000.00View SEC Filing  
10/13/2017Kim D BlickenstaffCEOBuy285,700$3.50$999,950.00View SEC Filing  
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.002,007,939View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.0022,763View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.007,295View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.007,295View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.009,295View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.004,084View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.004,084View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.004,084View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tandem Diabetes Care (NASDAQ TNDM) News Headlines

Source:
DateHeadline
Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New ZealandTandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand
finance.yahoo.com - April 23 at 5:13 PM
Pivotal Point For Tandem Diabetes CarePivotal Point For Tandem Diabetes Care
seekingalpha.com - April 20 at 5:21 PM
Tandem Diabetes Care Schedules First Quarter 2018 Earnings Press Release and Conference CallTandem Diabetes Care Schedules First Quarter 2018 Earnings Press Release and Conference Call
finance.yahoo.com - April 18 at 5:44 PM
Tandem Diabetes Care (TNDM) Given Consensus Rating of "Buy" by BrokeragesTandem Diabetes Care (TNDM) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 18 at 9:07 AM
Tandem Diabetes Care (TNDM) Scheduled to Post Quarterly Earnings on WednesdayTandem Diabetes Care (TNDM) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 4:20 AM
Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done YetTandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet
investorplace.com - April 13 at 11:45 AM
Tandem Diabetes (TNDM) Reports Prelim. Q1 Sales of $27MTandem Diabetes (TNDM) Reports Prelim. Q1 Sales of $27M
www.streetinsider.com - April 12 at 5:38 PM
Tandem Diabetes Care (TNDM) Upgraded at BidaskClubTandem Diabetes Care (TNDM) Upgraded at BidaskClub
www.americanbankingnews.com - April 11 at 11:01 AM
Tandem Diabetes Care Announces Preliminary First Quarter 2018 ResultsTandem Diabetes Care Announces Preliminary First Quarter 2018 Results
finance.yahoo.com - April 10 at 5:29 PM
Tandem Diabetes Care Inc (NASDAQ:TNDM): Are Analysts Bullish?Tandem Diabetes Care Inc (NASDAQ:TNDM): Are Analysts Bullish?
finance.yahoo.com - April 10 at 5:29 PM
Why Tandem Diabetes Care Is Soaring 18.5% Higher TodayWhy Tandem Diabetes Care Is Soaring 18.5% Higher Today
finance.yahoo.com - April 10 at 5:29 PM
25 Stocks Moving In Tuesdays Mid-Day Session25 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - April 10 at 1:27 PM
Tandem Diabetes sees 42% increase in Q1 sales; shares ahead 2% premarketTandem Diabetes sees 42% increase in Q1 sales; shares ahead 2% premarket
seekingalpha.com - April 10 at 9:42 AM
Tandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 7 at 10:52 AM
Tandem Diabetes Care (TNDM) Upgraded at ValuEngineTandem Diabetes Care (TNDM) Upgraded at ValuEngine
www.americanbankingnews.com - April 7 at 7:02 AM
Tandem Diabetes Care (TNDM) Expected to Post Quarterly Sales of $25.15 MillionTandem Diabetes Care (TNDM) Expected to Post Quarterly Sales of $25.15 Million
www.americanbankingnews.com - April 7 at 2:08 AM
Tandem Diabetes Care (TNDM) Cut to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 6 at 9:50 PM
Tandem Diabetes Care (TNDM) Given a $8.00 Price Target at OppenheimerTandem Diabetes Care (TNDM) Given a $8.00 Price Target at Oppenheimer
www.americanbankingnews.com - April 6 at 11:06 AM
-$0.60 EPS Expected for Tandem Diabetes Care (TNDM) This Quarter-$0.60 EPS Expected for Tandem Diabetes Care (TNDM) This Quarter
www.americanbankingnews.com - April 5 at 9:14 PM
Tandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment ResearchTandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 5 at 2:58 PM
Wall Street Brushes Off Trade War Fears: Top 5 GainersWall Street Brushes Off Trade War Fears: Top 5 Gainers
finance.yahoo.com - April 5 at 10:12 AM
Tandem Diabetes Care Stock Continued the Upward Trend Last WeekTandem Diabetes Care Stock Continued the Upward Trend Last Week
finance.yahoo.com - April 4 at 4:12 PM
Tandem Diabetes Care (TNDM) Shares March Higher, Can It Continue?Tandem Diabetes Care (TNDM) Shares March Higher, Can It Continue?
finance.yahoo.com - April 4 at 4:12 PM
Tandem Diabetes Care (TNDM) Cut to Hold at Zacks Investment ResearchTandem Diabetes Care (TNDM) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - March 31 at 10:54 AM
Tandem Diabetes Care Inc (TNDM) Short Interest UpdateTandem Diabetes Care Inc (TNDM) Short Interest Update
www.americanbankingnews.com - March 30 at 2:02 AM
Tandem Diabetes Care (TNDM) Upgraded to "Buy" by Zacks Investment ResearchTandem Diabetes Care (TNDM) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - March 29 at 1:58 PM
Tandem Diabetes Care (TNDM) Upgraded to "Outperform" by CowenTandem Diabetes Care (TNDM) Upgraded to "Outperform" by Cowen
www.americanbankingnews.com - March 28 at 8:05 AM
Tandem Diabetes Care (TNDM) Now Covered by CitigroupTandem Diabetes Care (TNDM) Now Covered by Citigroup
www.americanbankingnews.com - March 24 at 10:02 PM
Tandem Diabetes Care Inc (TNDM) Receives Consensus Rating of "Hold" from AnalystsTandem Diabetes Care Inc (TNDM) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 9:18 AM
Baird Sees Improved Odds Tandem Diabetes Care Will SurviveBaird Sees 'Improved Odds' Tandem Diabetes Care Will Survive
finance.yahoo.com - March 24 at 8:50 AM
Tandem Diabetes Care (TNDM) Raised to Outperform at Robert W. BairdTandem Diabetes Care (TNDM) Raised to Outperform at Robert W. Baird
www.americanbankingnews.com - March 23 at 6:49 PM
Tandem Diabetes Care (TNDM) Lowered to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 23 at 10:09 AM
How Did Tandem Diabetes Care Inc’s (NASDAQ:TNDM) Earnings Growth Stack Up Against The Industry?How Did Tandem Diabetes Care Inc’s (NASDAQ:TNDM) Earnings Growth Stack Up Against The Industry?
finance.yahoo.com - March 22 at 5:35 PM
Tandem Diabetes Care (TNDM) Receives "Buy" Rating from OppenheimerTandem Diabetes Care (TNDM) Receives "Buy" Rating from Oppenheimer
www.americanbankingnews.com - March 22 at 4:05 PM
Tandem Diabetes Care (TNDM) Raised to Buy at Zacks Investment ResearchTandem Diabetes Care (TNDM) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - March 22 at 2:20 PM
Zacks: Analysts Anticipate Tandem Diabetes Care Inc (TNDM) Will Post Quarterly Sales of $25.15 MillionZacks: Analysts Anticipate Tandem Diabetes Care Inc (TNDM) Will Post Quarterly Sales of $25.15 Million
www.americanbankingnews.com - March 21 at 2:34 AM
Zacks: Brokerages Expect Tandem Diabetes Care Inc (TNDM) to Announce -$0.60 Earnings Per ShareZacks: Brokerages Expect Tandem Diabetes Care Inc (TNDM) to Announce -$0.60 Earnings Per Share
www.americanbankingnews.com - March 19 at 9:14 PM
Free Research Reports on These Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Tandem ... - PR Newswire (press release)Free Research Reports on These Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Tandem ... - PR Newswire (press release)
www.prnewswire.com - March 16 at 8:21 AM
Tandem Diabetes Care (TNDM) Presents At 38th Annual Cowen And Company Healthcare Conference - SlideshowTandem Diabetes Care (TNDM) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 15 at 6:11 PM
Short Interest in Tandem Diabetes Care Inc (TNDM) Grows By 48.9%Short Interest in Tandem Diabetes Care Inc (TNDM) Grows By 48.9%
www.americanbankingnews.com - March 13 at 1:53 AM
Tandem Diabetes Care (TNDM) PT Doubled to $5 at Cowen; Outlook Improved SignificantlyTandem Diabetes Care (TNDM) PT Doubled to $5 at Cowen; Outlook Improved Significantly
www.streetinsider.com - March 10 at 6:23 PM
Tandem Diabetes Care (TNDM) Downgraded to Sell at ValuEngineTandem Diabetes Care (TNDM) Downgraded to Sell at ValuEngine
www.americanbankingnews.com - March 8 at 12:28 AM
Tandem Diabetes Care Inc (TNDM) Director Dick Allen Purchases 25,539 SharesTandem Diabetes Care Inc (TNDM) Director Dick Allen Purchases 25,539 Shares
www.americanbankingnews.com - March 7 at 7:14 PM
Tandem Diabetes Care Announces Upcoming Conference PresentationsTandem Diabetes Care Announces Upcoming Conference Presentations
finance.yahoo.com - March 7 at 6:33 PM
Tandem Diabetes Care (TNDM) Upgraded to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 7 at 12:49 PM
Tandem Diabetes Care (TNDM) Downgraded by ValuEngineTandem Diabetes Care (TNDM) Downgraded by ValuEngine
www.americanbankingnews.com - March 4 at 2:24 PM
Tandem Diabetes Care Inc (TNDM) Expected to Post Quarterly Sales of $25.86 MillionTandem Diabetes Care Inc (TNDM) Expected to Post Quarterly Sales of $25.86 Million
www.americanbankingnews.com - March 4 at 2:38 AM
Tandem Diabetes Cares (TNDM) Hold Rating Reaffirmed at Stifel NicolausTandem Diabetes Care's (TNDM) Hold Rating Reaffirmed at Stifel Nicolaus
www.americanbankingnews.com - March 3 at 12:30 PM
-$2.07 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter-$2.07 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - March 2 at 8:22 PM
Tandem Diabetes Care (TNDM) Posts Quarterly  Earnings Results, Misses Estimates By $0.13 EPSTandem Diabetes Care (TNDM) Posts Quarterly Earnings Results, Misses Estimates By $0.13 EPS
www.americanbankingnews.com - March 2 at 12:44 PM

SEC Filings

Tandem Diabetes Care (NASDAQ:TNDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tandem Diabetes Care (NASDAQ:TNDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tandem Diabetes Care (NASDAQ TNDM) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.